Background: Metastatic pancreatic ductal adenocarcinoma (mPDAC) is an aggressive malignancy with a median overall survival (mOS) of between 8 and 11 months. With the use of modern chemotherapy ...

Grünenthal has moved its painkiller resiniferatoxin into phase 3 trials in patients with osteoarthritis, hoping to find an option that sidesteps the side effects and addictive potential of opioid ...

Metro-3 Phase 2 And Final Stretch Of Samruddhi Expressway Likely To Open On May 1; PM Modi May Inaugurate Projects According to sources, efforts are underway to inaugurate both projects through ...

In this paper, a wind energy conversion system (WECS) is presented for the electrification of rural areas with wind energy availability. A three-phase AC-DC converter based on a bridgeless Cuk ...

Power filters have been widely used to suppress switching harmonics caused by the modulation of grid-connected inverters. In order to save the total inductance and cost and reduce the volume, ...

Firmware supporting the Application Note AN3607 'Phase Sequence Detection of Three Phase AC Supply'. This application demonstrates phase sequence detection, RMS voltage measurement on the three-phase ...

Introduction Genetic and clinical evidence has shown that interleukin-33 plays a key role in the susceptibility and progression of asthma. The phase 2a FRONTIER-3 study ([NCT04570657][1]) investigated ...

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced ...

CHICAGO — Positive interpretations of randomized phase 3 oncology trials often are based on improvements in unvalidated alternative endpoints, findings presented at ASCO Annual Meeting showed ...

Otsuka Pharmaceutical has shared more detailed data behind its kidney disease drug’s phase 3 win, showing the monoclonal antibody halved patients’ urine protein-to-creatinine ratio (UPCR) levels.

Background: Relacorilant is an investigational, oral, selective glucocorticoid receptor antagonist (SGRA) that increases tumor sensitivity to chemotherapy-induced apoptosis. In a phase 2 study, the ...

Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday.